DistillerSR

What is DistillerSR?

DistillerSR (distillersr.com) is the premier enterprise software platform for automating literature reviews and evidence synthesis. Engineered for pharmaceutical corporations, medical device leaders, contract research organizations (CROs), government bodies, and academic health systems, it solves the challenge of scaling complex systematic reviews while maintaining strict regulatory compliance.

By uniting AI-enabled re-ranking, smart screening classifiers, automated error checking, and audit-ready version control, DistillerSR converts labor-intensive paper reviews into standardized, automated workflows. Trusted by top healthcare companies globally, it accelerates Clinical Evaluation Reports (CERs), Health Economics and Outcomes Research (HEOR), post-market surveillance (PMS), and pharmacovigilance while ensuring 100% auditability.

• Platform Focus: Enterprise AI literature reviews, regulatory compliance, evidence reuse, automated data extraction, and audit trails
• Developer / Entity: DistillerSR Inc.
• Launch Year: Enterprise Literature Evidence Synthesis Platform

Use Cases:

• Authoring Clinical Evaluation Reports (CERs) and Performance Evaluation Reports (PERs) for FDA and EU MDR/IVDR regulatory submissions
• Executing large-scale systematic literature reviews, rapid reviews, and scoping syntheses
• Automating post-market surveillance (PMS), signal detection, and pharmacovigilance monitoring
• Conducting Health Economics and Outcomes Research (HEOR) and clinical guideline development
• Centralizing evidence across global teams to prevent duplicate research and build reusable organizational literature databases

Technology:

• Human-in-the-loop AI screening engine featuring real-time AI Re-Rank, smart prioritization, and PICO classifiers
• Smart Evidence Extraction (SEE) parsing tabular data, outcomes, and qualitative study variables
• Enterprise compliance architecture adhering to SOC 2 Type II, FDA 21 CFR Part 11, EU Annex 11, and NIST AI Risk Management Frameworks
• REST API and Business Intelligence integrations connecting directly to Power BI, Tableau, and custom data warehouses

Target Users:

• Regulatory affairs, medical writing, and clinical evaluation teams at medical device and pharma enterprises
• Pharmacovigilance managers and safety officers conducting ongoing literature surveillance
• Government research bodies, public health institutes, and Health Technology Assessment (HTA) agencies
• Academic medical centers and health sciences libraries managing high-volume review portfolios

Corporate Entity: Operates as DistillerSR Inc. / distillersr.com

Key features of DistillerSR

DistillerSR's key features are

• AI Screening & Re-Rank: Dynamically prioritizes inclusion/exclusion candidates in real-time, reducing screening times by up to 60-70%.
• AI Error Checking: Automatically scans excluded reference lists to catch and flag potential human reviewer screening mistakes.
• Smart Evidence Extraction (SEE): Standardizes and automates data collection using customizable forms, templates, and response validation rules.
• Audit-Ready Version Control: Complete 100% traceable logging compliant with FDA 21 CFR Part 11 and EU Annex 11 regulations.
• Centralized Evidence Repository: Centralizes research data across departments to enable evidence reuse and prevent duplicate work.
• BI & API Integrations: Connects literature evidence datasets directly to Power BI, Tableau, and external enterprise systems.

DistillerSR Pricing

DistillerSR operates on a tiered licensing structure tailored to enterprise corporate teams, government agencies, and academic researchers.

Academic & Student Tiers:

• Student plan starting around ~$19.95 (multi-subscription bundles)
• Faculty / Individual Academic plans starting around ~$94 / month per subscription
• Includes full review workflows, standard AI features, and export options for university researchers

Corporate, Pharma & Government Tiers:

• Custom annual enterprise license pricing
• Includes multi-seat enterprise access, FDA 21 CFR Part 11 compliance, SOC 2 security, BI tool integrations, dedicated customer success, and managed onboarding services

Who is using DistillerSR?

DistillerSR is designed for enterprise life science and regulatory research teams, including

• Pharma & Biotech Regulatory Teams: Conducting pharmacovigilance and preparing global drug safety submissions
• Medical Device Companies: Streamlining EU MDR and FDA Clinical Evaluation Reports (CERs)
• Government & HTA Agencies: Synthesizing public health evidence and policy guidelines at scale

Best DistillerSR Alternatives

Some of the strongest DistillerSR alternatives include

• Covidence
• Rayyan
• EPPI-Reviewer
• Nested Knowledge
• Paperguide
• RevMan

Pros and Cons of DistillerSR

Pros

• Industry-leading regulatory compliance framework (FDA 21 CFR Part 11, SOC 2 Type II, EU Annex 11)
• Capable of managing massive enterprise projects containing over 700,000+ references smoothly
• Human-in-the-loop AI Re-Rank and error checking cut screening time while preserving accuracy
• Enables evidence reuse across an entire global enterprise to eliminate duplicate research costs

Cons

• Enterprise corporate licenses require custom sales quotes and represent significant investment for small teams
• Comprehensive feature set and extensive configuration options present a steeper initial learning curve
• Focuses strictly on literature processing rather than consumer generative writing or PDF conversational chat

Why Choose DistillerSR?

DistillerSR is the clear choice for corporate life science enterprises, CROs, and government healthcare organizations that require an audit-ready, AI-driven platform built to handle regulatory-grade literature reviews and large-scale evidence management.

• Meets strict global regulatory compliance standards (FDA 21 CFR Part 11, EU Annex 11, SOC 2)
• Accelerates literature screening by 35%-50%+ with AI Re-Rank and automated error checking
• Breaks down organizational research silos by building a centralized, reusable evidence repository
• Integrates with Business Intelligence tools (Power BI, Tableau) via robust API pipelines

DistillerSR vs. Competitors

The main difference between DistillerSR, Covidence, Rayyan, and EPPI-Reviewer is that DistillerSR is an enterprise B2B platform engineered for corporate regulatory compliance (FDA 21 CFR Part 11), pharmacovigilance, and medical device CER submissions with business intelligence integrations, whereas Covidence focuses on Cochrane clinical systematic reviews, Rayyan offers low-cost citation screening, and EPPI-Reviewer specializes in non-profit qualitative/mixed-methods research. DistillerSR stands out for its enterprise compliance, scalability, and evidence reuse infrastructure.

How do we rate DistillerSR?

DistillerSR Review

DistillerSR is the benchmark enterprise software platform for evidence synthesis and regulatory literature reviews. By pairing human-in-the-loop AI screening and error checking with strict FDA 21 CFR Part 11 and SOC 2 Type II compliance, it provides a secure, audit-ready environment for life science leaders. Its ability to centralize organizational literature, enable evidence reuse, and export directly to BI platforms makes it indispensable for high-stakes pharma and medical device submissions.

Conclusion

DistillerSR is an enterprise AI-enabled literature review platform that sets the standard for evidence management. By combining intelligent screening, smart data extraction, full regulatory compliance, and seamless enterprise integration into a unified software suite, it enables global healthcare leaders to deliver compliant research faster and more accurately.